Clinical Trial Update: Repurposing Tilmanocept for Cardiac Sarcoidosis [Phase 2]

View source ↗

Summary

Duke University is conducting a Phase 2 clinical trial to repurpose tilmanocept (Lymphoseek) for cardiac sarcoidosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Sarcoidosis

Drugs mentioned

• Lymphoseek (tilmanocept)

Snippet

Sponsor: Duke University | Conditions: Cardiac Sarcoidosis | Phase 2 | Status: RECRUITING